The Fallacy of IPAP: Correcting 35 Years of Treating OSA Backwards

Meet the Professors and the Inventor in this 90-minute webinar with 1.5 CME/CE/CEU credits composed of three 25-minute presentations with discussion to follow.

First, Peter Gay, MD (Professor of Medicine at the Mayo Clinic) will review 30 years of randomized trials with BPAP and expiratory pressure reduction (EPR) algorithms failing to increase adherence over CPAP, and present when higher IPAP is actually needed.

Second, William H. Noah, MD (inventor of V-Com® and KairosPAP™ or KPAP™), will discuss the history, physics, and physiology of positive airway pressure (PAP) therapy and how current CPAP and bilevel PAP (BPAP) devices are engineered with the wrong understanding of OSA.

Finally, David P. White, MD (former editor-in-chief of SLEEP, AASM President, and Professor of Medicine at Harvard Medical School) will review the results of six recent clinical trials with either V-Com or KPAP providing the same efficacy as CPAP despite reducing the IPAP as much as 5 cmH2O below EPAP with much more comfort, increased usage
time, and decreased side effects.

A Q&A session will follow the presentation.

Earn 1.50 CME, ADA, CSTE, CRCE

Learning Objectives

1. To educate the audience regarding the human pharyngeal airway and how it responds to positive pressure and reductions in positive pressure, particularly during expiration and sleep.

2. To review the published literature on the effects of lowering expiratory pressure on satisfaction and adherence to CPAP.

3. To propose a new algorithm for pressure delivery with lower inspiratory and expiratory pressure (other than at end expiration) and the comfort and efficacy of such an algorithm in treating OSA.

Accreditation

See below.

There is no charge for this webinar.

About the Speakers

Peter Gay, MD, received his B.A. from Middlebury College, Middlebury, VT, and an MS in Physiology and MD degrees at the University of Hawaii, Honolulu, HI, where he grew up. He trained at the Mayo Clinic, Rochester, and is board-certified in internal medicine, subspecialty pulmonary disease, critical Care medicine, and sleep medicine. He has been at Mayo in his current position for 36 years now. He has been dedicated to regulatory advocacy efforts, research, and clinical care in support of patients with various disorders leading to chronic hypercapnic respiratory failure.

William Noah, MD, is the Medical Director of Sleep Centers of Middle Tennessee, which has multiple clinic locations, including Murfreesboro, Franklin/Nashville, and Clarksville. He also founded OSAinHome, a comprehensive solution for sleep apnea testing, and is a founding member of the Middle Tennessee State University Sleep Research Consortium.

David P. White, MD, was the first Gerald E. McGinnis Professor of Medicine at Harvard Medical School, where he trained many of today’s leaders in sleep medicine. He is a former editor-in-chief of the journal SLEEP, president of the American Academy of Sleep Medicine, and chairman of the NIH's sleep research task force. He also served as Chief Medical Officer for Respironics and Philips Respironics until 2013. With 300 publications, he continues his primary research at Harvard, focusing on the pathophysiology of sleep breathing disorders.

This program has been approved for a maximum of 1.50 contact hours Continuing Sleep Technology Education (CSTE) credit by the Board of Registered Polysomnographic Technologists, 4201 Wilson Blvd., 3rd Floor, Arlington, VA 22203 Course #575P1779 Program ID #711725.

This program has been approved for a maximum of 1.50 contact hours of Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd. Suite 100, Irving, TX 75063. Course #1943570000